HomeKRYS • NASDAQ
add
Krystal Biotech Inc
Previous close
$179.25
Day range
$170.43 - $179.12
Year range
$141.72 - $219.34
Market cap
4.94B USD
Avg Volume
254.46K
P/E ratio
57.32
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 91.14M | 116.26% |
Operating expense | 44.81M | 24.01% |
Net income | 45.48M | 423.23% |
Net profit margin | 49.90 | 142.00% |
Earnings per share | 1.53 | 59.81% |
EBITDA | 41.64M | 934.35% |
Effective tax rate | 6.44% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 597.52M | 12.28% |
Total assets | 1.06B | 29.02% |
Total liabilities | 109.46M | 175.62% |
Total equity | 946.38M | — |
Shares outstanding | 28.81M | — |
Price to book | 5.45 | — |
Return on assets | 10.15% | — |
Return on capital | 11.20% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 45.48M | 423.23% |
Cash from operations | 52.84M | 830.68% |
Cash from investing | -83.78M | -724.59% |
Cash from financing | 2.43M | -7.29% |
Net change in cash | -29.10M | -95.14% |
Free cash flow | 31.73M | 266.58% |
About
Founded
2015
Headquarters
Website
Employees
275
